The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CLDN6 CAR-T cell therapy of relapsed/refractory solid tumors ± a CLDN6-encoding mRNA vaccine: Dose escalation data from the BNT211-01 phase 1 trial using an automated product.
 
Andreas Mackensen
Honoraria - Bristol-Myers Squibb/Celgene; KITE/Gilead; Miltenyi Biomedicine; Novartis Pharmaceuticals UK Ltd.
Consulting or Advisory Role - BioNTech; Bristol-Myers Squibb/Celgene; KITE/Gilead; Miltenyi Biomedicine; Novartis
Research Funding - Kyverna Therapeutics; Miltenyi Biotec
 
John B. A. G. Haanen
Stock and Other Ownership Interests - Neogene Therapeutics
Consulting or Advisory Role - Achilles Therapeutics (Inst); bioNTech (Inst); Bristol-Myers Squibb (Inst); Immunocore (Inst); Instil Bio (Inst); Iovance Biotherapeutics (Inst); Ipsen (Inst); Molecular Partners (Inst); MSD Oncology (Inst); Neogene Therapeutics; Novartis (Inst); Pfizer (Inst); POEM Health (Inst); Roche/Genentech (Inst); Sanofi (Inst); T-Knife (Inst); Third Rock Ventures (Inst)
Research Funding - Amgen (Inst); Asher Biotherapeutics (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Neon Therapeutics (Inst); Novartis (Inst)
 
Christian Koenecke
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Kite, a Gilead Company; Medigene; Novartis; Pierre Fabre; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Janssen
 
Winfried Alsdorf
Research Funding - BioNTech (Inst)
Travel, Accommodations, Expenses - BioNTech; Janssen
 
Eva Maria Wagner-Drouet
Consulting or Advisory Role - Bristol-Myers Squibb; Kite/Gilead; Novartis
Travel, Accommodations, Expenses - BMS GmbH & Co. KG; Kite/Gilead
 
Daniel Heudobler
Honoraria - Abbvie
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Janssen-Cilag; MSD; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
Research Funding - Bristol-Myers Squibb; Janssen-Cilag
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Janssen-Cilag
 
Peter Borchmann
Honoraria - BMS Germany; MSD Oncology
Research Funding - MSD Oncology (Inst); Takeda (Inst)
 
Carsten Bokemeyer
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Hexal; I-Med Institute; Medac; Medupdate; Merck KGaA; Merck Sharp Dohme; Roche; Sanofi
Consulting or Advisory Role - AOK Health Insurance; Bayer Schering Pharma; BioNTech SE; GSO; Janssen-Cilag GmbH; Merck Sharp & Dohme; Oncology Drug Consult (ODC); Sanofi
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Agile Therapeutics (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); Apellis Pharmaceuticals (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BerGenBio (Inst); BioNTech SE (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); CPT Cellex Patient Treatment (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Glycostem (Inst); Glycotope GmbH (Inst); immatics (Inst); Incyte (Inst); IO Biotech (Inst); Ipsen (Inst); Isofol Medical (Inst); Janssen-Cilag (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Millennium (Inst); MSD (Inst); Nektar (Inst); Novartis (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Servier/Pfizer (Inst); Springworks Therapeutics (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Janssen-Cilag; Merck Serono; Sanofi
 
Sebastian Klobuch
No Relationships to Disclose
 
Nadine Kutsch
Honoraria - AstraZeneca; BMS; Roche
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst)
Travel, Accommodations, Expenses - AbbVie; Celgene; Gilead Sciences; Janssen
 
Fabian Müller
Consulting or Advisory Role - Abbvie; BMS Brazil; Gilead Sciences; Miltenyi Biotec; Novartis
Speakers' Bureau - Abbvie; BMS Brazil; Gilead Sciences; Janssen; Miltenyi Biotec; Novartis
Research Funding - MedImmune
Travel, Accommodations, Expenses - Abbvie; BMS Brazil; Gilead Sciences; Janssen; Miltenyi Biotec; Novartis
 
Alexander Desuki
Consulting or Advisory Role - BMS GmbH & Co. KG; Janssen-Cilag; Roche
Speakers' Bureau - Bristol-Myers Squibb; Janssen-Cilag; Roche
Travel, Accommodations, Expenses - BMS GmbH & Co. KG
 
Florian Lüke
Honoraria - Janssen; Roche
Consulting or Advisory Role - Janssen; MSD
Research Funding - Novartis
Travel, Accommodations, Expenses - Janssen; MSD
 
Erol Wiegert
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb
Speakers' Bureau - AstraZeneca; Roche
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Gilead Sciences; Janssen
 
Carina Flemmig
Employment - BioNTech SE
Stock and Other Ownership Interests - BioNTech SE
 
Catrine Schulz-Eying
Employment - BioNTech
Stock and Other Ownership Interests - BioNTech
Research Funding - BioNTech
 
Benjamin Rengstl
Employment - BioNTech
Stock and Other Ownership Interests - BioNTech
Research Funding - BioNTech
Patents, Royalties, Other Intellectual Property - BioNTech
Travel, Accommodations, Expenses - BioNTech
 
Liane Preußner
Employment - BioNTech
Stock and Other Ownership Interests - BioNTech
Research Funding - Liane Preußner
Travel, Accommodations, Expenses - BioNTech
 
Özlem Türeci
Employment - BioNTech
Leadership - BioNTech
Stock and Other Ownership Interests - BioNTech
Research Funding - BioNTech
Patents, Royalties, Other Intellectual Property - I am inventor of many patents that are exploited by the industry
Travel, Accommodations, Expenses - BioNTech
 
Uğur Şahin
Employment - BioNTech
Leadership - BioNTech
Stock and Other Ownership Interests - BioNTech
Research Funding - BioNTech
Patents, Royalties, Other Intellectual Property - I am inventor of many patents that are exploited by the industry
Travel, Accommodations, Expenses - BioNTech